UNC Lineberger Comprehensive Cancer Center: all 424 studies

Page 2 of 5. Open to participants first (96), then studies with results posted, then the rest; newest registration first within each.

• Impact of E-Cigarette Prevention Messages on AdolescentsCompletedNCT05985538Not applicableResults posted
• Isa-Pom-Dex in Elderly/Frail Subjects With RRMMActive, not recruitingNCT05911321Phase 2Results posted
• Physical Activity and Healthy Eating Among Young Adult Cancer SurvivorsCompletedNCT05887401Not applicableResults posted
• Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCsCompletedNCT05849051Not applicableResults posted
• Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive InterventionsCompletedNCT05751993Not applicableResults posted
• Impact of E-cigarette Device WarningsCompletedNCT05714982Not applicableResults posted
• Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell LymphomaTerminatedNCT05498220Phase 2Results posted
• Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIVCompletedNCT05413811Not applicableResults posted
• The Families Addressing Cancer Together Intervention for Parents With CancerCompletedNCT05377749Not applicableResults posted
• Mobile Coaching to Improve HPV Vaccine DeliveryCompletedNCT05105711Not applicableResults posted
• Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling SurveyCompletedNCT05061095Results posted
• Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®CompletedNCT05011890Not applicableResults posted
• Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple MyelomaCompletedNCT04999085Not applicableResults posted
• Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility StudyCompletedNCT04978350Not applicableResults posted
• Correcting Public Misperceptions About Very Low Nicotine Content CigarettesCompletedNCT04974489Not applicableResults posted
• Addressing Cancer-Related Financial Toxicity in North Carolina Oncology Care SettingsCompletedNCT04931251Not applicableResults posted
• Impact of Vaping Prevention AdvertisementsCompletedNCT04836455Not applicableResults posted
• Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial OvarianActive, not recruitingNCT04670068Phase 1Results posted
• Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in MalawiCompletedNCT04585893Phase 2Results posted
• RN-Led Palliative and Supportive Care InterventionCompletedNCT04570709Not applicableResults posted
• A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS LymphomasActive, not recruitingNCT04548648Phase 2Results posted
• Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell TransplantsCompletedNCT04535141Phase 3Results posted
• Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)CompletedNCT04492007Not applicableResults posted
• Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)CompletedNCT04406714Not applicableResults posted
• Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramCompletedNCT04350788Not applicableResults posted
• An Evaluation of the Families Addressing Cancer Together (FACT) InterventionCompletedNCT04342871Not applicableResults posted
• Improving Quality of Life After Thoracic Surgery Using Patient-Reported OutcomesCompletedNCT04342260Not applicableResults posted
• PET/MR Characterization of Renal Cell CarcinomasTerminatedNCT04271254Not applicableResults posted
• PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot StudyTerminatedNCT04176497Phase 2Results posted
• PET/MR in Surgical Planning for Breast CA Treated With Neoadj ChemoTerminatedNCT04149353Not applicableResults posted
• 3-D Super Resolution Ultrasound Microvascular ImagingTerminatedNCT04136912Phase 2Results posted
• Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot InterventionTerminatedNCT04092816Not applicableResults posted
• HPV-Based Screen-and-Treat Demonstration Project in LilongweCompletedNCT04092257Not applicableResults posted
• Clinical Evaluation of Primary Sampling Scatter Correction for Chest TomosynthesisCompletedNCT04076696Not applicableResults posted
• Memantine for Prevention of Cognitive Decline in Patients With Breast CancerCompletedNCT04033419Phase 2Results posted
• High Intensity Interval Training in Endometrial CancerCompletedNCT04025229Not applicableResults posted
• Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and StagingCompletedNCT04021238Phase 2Results posted
• Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder CancerActive, not recruitingNCT03978624Phase 2Results posted
• Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel LindauCompletedNCT03907657Phase 2Results posted
• Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility StudyCompletedNCT03846947Not applicableResults posted
• MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored FeedbackCompletedNCT03820024Not applicableResults posted
• ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast CancerCompletedNCT03785782Results posted
• An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV MelanomaCompletedNCT03765229Phase 2Results posted
• Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell LymphomaActive, not recruitingNCT03696784Phase 1Results posted
• Home-based Exercise Intervention for Patients With Metastatic Prostate CancerCompletedNCT03672396Not applicableResults posted
• Denosumab + PD-1 in Subjects With Stage III/ IV MelanomaCompletedNCT03620019Phase 2Results posted
• A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural EffusionTerminatedNCT03597009Phase 1/2Results posted
• Trial of Parotid Sparing Whole Brain RadiationCompletedNCT03595878Not applicableResults posted
• Academic-Industrial Partnership for Translation of Acoustic AngiographyCompletedNCT03544268Phase 4Results posted
• Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHNCompletedNCT03529422Phase 2Results posted
• Efficacy of a Couple-Focused mHealth Symptom Self-management ProgramCompletedNCT03489057Not applicableResults posted
• Palbociclib and Cetuximab in Metastatic Colorectal CancerCompletedNCT03446157Phase 2Results posted
• PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRCCompletedNCT03442569Phase 2Results posted
• Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone PainTerminatedNCT03407430Phase 2Results posted
• Enhancing Source Credibility in Tobacco Regulatory CommunicationsCompletedNCT03339206Not applicableResults posted
• BV-CHEP Chemotherapy for Adult T-cell Leukemia or LymphomaCompletedNCT03264131Phase 2Results posted
• High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT03263442Phase 2Results posted
• Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT03174275Phase 2Results posted
• Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging BiomarkerCompletedNCT03089606Phase 2Results posted
• P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCCCompletedNCT03077243Phase 2Results posted
• PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade SarcomasCompletedNCT03076333Not applicableResults posted
• High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AMLCompletedNCT02768792Phase 2Results posted
• Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast CancerCompletedNCT02768701Phase 2Results posted
• Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant TherapyCompletedNCT02690558Phase 2Results posted
• Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxelCompletedNCT02684461Phase 2Results posted
• Administration of T Lymphocytes for Prevention of Relapse of LymphomasActive, not recruitingNCT02663297Phase 1Results posted
• Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible CisplatinCompletedNCT02609503Phase 2Results posted
• North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)CompletedNCT02564120Results posted
• Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line ChemotherapyTerminatedNCT02334527Phase 2Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• Cisplatin and Nab-paclitaxel for (N2) Defined NSCLCTerminatedNCT02276560Phase 2Results posted
• Comparison of the Sensitivity and Specificity of Acoustic Angiography to the Sensitivity and Specificity of Conventional UltrasoundCompletedNCT02175628Not applicableResults posted
• Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal CancerCompletedNCT02138617Phase 2Results posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung NodulesCompletedNCT02075320Not applicableResults posted
• Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical PatientsCompletedNCT02035787Phase 2Results posted
• Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal CancerTerminatedNCT02010567Phase 1/2Results posted
• LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional MutationsCompletedNCT01726738Phase 2Results posted
• Single Arm on the Tolerability of Weekly Nab-paclitaxelCompletedNCT01702844Phase 2Results posted
• FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic CancerTerminatedNCT01688336Phase 2Results posted
• Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral SurgeryCompletedNCT01612351Phase 2Results posted
• Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin LymphomaCompletedNCT01578967Not applicableResults posted
• Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)CompletedNCT01573702Phase 2Results posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver MetastasesCompletedNCT01528878Not applicableResults posted
• Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01488487Phase 2Results posted
• Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment DecisionsCompletedNCT01457196Not applicableResults posted
• Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01412229Phase 2Results posted
• Neoadjuvant Pazopanib in Renal Cell CarcinomaCompletedNCT01361113Phase 2Results posted
• Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersCompletedNCT01344824Phase 2Results posted
• A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain MetastasesCompletedNCT01305941Phase 2Results posted
• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerCompletedNCT01298570Phase 2Results posted
• Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing BevacizumabCompletedNCT01262820Phase 2Results posted
• Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell LymphomaCompletedNCT01234467Phase 2Results posted
• Trisenox® in Women With Metastatic Endometrial CancerTerminatedNCT01184053Phase 2Results posted
• Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving TamoxifenCompletedNCT00764322Phase 2Results posted
• Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCTerminatedNCT00519831Phase 2Results posted
• Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous SteroidsTerminatedNCT00489216Not applicableResults posted
• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver CancerCompletedNCT00483405Phase 2Results posted
• Study of Abraxane and Carboplatin to Treat Small Cell Lung CancerTerminatedNCT00454324Phase 2Results posted

← UNC Lineberger Comprehensive Cancer Center overview and focus areas